177 results
Page 6 of 9
8-K
EX-4.1
faugu fqemhymtofiz8f
29 Jan 14
Emergent Biosolutions Announces Completion of $250 Million Convertible Senior Notes Offering
12:00am
8-K
EX-2
3cmkg0h7xfskb6l12o0s
12 Dec 13
Emergent Biosolutions to Acquire Cangene Corporation
12:00am
8-K
EX-10.1
tknpz jud3otj
12 Dec 13
Emergent Biosolutions to Acquire Cangene Corporation
12:00am
8-K
EX-99
tzvzdatg5q153vwiom
4 Feb 13
Data from Historic Phase IIb Clinical Trial for Tuberculosis Vaccine Candidate MVA85A Published in The Lancet
12:00am